middle.news
Invex Therapeutics Cuts Losses Sharply, Advances Alzheimer’s Drug Research
9:30am on Friday 7th of February, 2025 AEDT
•
Biopharmaceutical
Read Story
Invex Therapeutics Cuts Losses Sharply, Advances Alzheimer’s Drug Research
9:30am on Friday 7th of February, 2025 AEDT
Key Points
Net loss narrowed to $356,535 from $2.1 million year-on-year
Entered research collaboration with Tessara Therapeutics on Alzheimer’s Disease
Exenatide showed protective effects in 3D human brain tissue models
Cash reserves remain strong at $5.8 million
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Invex Therapeutics (ASX:IXC)
OPEN ARTICLE